Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jul;182(7):3033-3044.
doi: 10.1007/s00431-023-04978-2. Epub 2023 May 6.

Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis

Javier Arredondo Montero et al. Eur J Pediatr. 2023 Jul.

Erratum in

Abstract

The aim of this study was to analyze the diagnostic performance of Leucine-Rich Alpha-2-Glycoprotein (LRG1) in pediatric acute appendicitis (PAA). We conducted a systematic review of the literature in the main databases of medical bibliography. Two independent reviewers selected the articles and extracted relevant data. Methodological quality was assessed using the QUADAS2 index. A synthesis of the results, standardization of the metrics and 4 random-effect meta-analyses were performed. Eight studies with data from 712 participants (305 patients with confirmed diagnosis of PAA and 407 controls) were included in this review. The random-effect meta-analysis of serum LRG1 (PAA vs control) resulted in a significant mean difference (95% CI) of 46.76 μg/mL (29.26-64.26). The random-effect meta-analysis for unadjusted urinary LRG1 (PAA vs control) resulted in a significant mean difference (95% CI) of 0.61 μg/mL (0.30-0.93). The random-effect meta-analysis (PAA vs control) for urinary LRG1 adjusted for urinary creatinine resulted in a significant mean difference (95% CI) of 0.89 g/mol (0.11-1.66). Conlusion: Urinary LRG1 emerges as a potential non-invasive biomarker for the diagnosis of PAA. On the other hand, due to the high between-study heterogeneity, the results on serum LRG1 should be interpreted with caution. The only study that analyzed salivary LRG1 showed promising results. Further prospective studies are needed to confirm these findings. What is Known: • Pediatric acute appendicitis continues to be a pathology with a high rate of diagnostic error. • Invasive tests, although useful, are a source of stress for patients and their parents. What is New: • LRG1 emerges as a promising urinary and salivary biomarker for the noninvasive diagnosis of pediatric acute appendicitis.

Keywords: Acute appendicitis; Children; LRG1; Leucine-Rich Alpha-2-Glycoprotein; Meta-analysis; Pediatric; Sensitivity; Specificity; Systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flowchart of the search and selection process
Fig. 2
Fig. 2
Graphical representation of the quality assessment of the diagnostic accuracy studies included in the review (QUADAS2)
Fig. 3
Fig. 3
A Forest plot of the random-effects meta-analysis performed for serum LRG1 (PAA group vs. Control group). B Forest plot of the random-effects meta-analysis performed for unadjusted urinary LRG1 (PAA group vs Control group). C Forest plot of the random-effects meta-analysis performed for adjusted-for-creatinine urinary LRG1 (PAA group vs Control group). D Forest plot of the random-effects meta-analysis performed for adjusted-for-creatinine urinary LRG1 (PAA group vs Control group) excluding Mahalik et al

References

    1. Jones MW, Lopez RA, Deppen JG (2022) Appendicitis. 2022 Oct 24. In: StatPearls. Treasure Island (FL): StatPearls Publishing. (PMID: 29630245) - PubMed
    1. Michelson KA, Reeves SD, Grubenhoff JA, Cruz AT, Chaudhari PP, Dart AH, Finkelstein JA, Bachur RG (2021) Clinical Features and Preventability of Delayed Diagnosis of Pediatric Appendicitis. JAMA Netw Open 4(8):e2122248. 10.1001/jamanetworkopen.2021.22248. (PMID: 34463745; PMCID: PMC8408667) - PMC - PubMed
    1. Goyal MK, Chamberlain JM, Webb M, Grundmeier RW, Johnson TJ, Lorch SA, Zorc JJ, Alessandrini E, Bajaj L, Cook L, Alpern ER, Pediatric Emergency Care Applied Research Network (PECARN) (2021) Racial and ethnic disparities in the delayed diagnosis of appendicitis among children. Acad Emerg Med 28(9):949–956. 10.1111/acem.14142. (Epub 2020 Oct 21. PMID: 32991770) - PubMed
    1. Michelson KA, McGarghan FLE, Patterson EE, Waltzman ML, Samuels-Kalow ME, Greco KF (2022) Clinician factors associated with delayed diagnosis of appendicitis. Diagnosis (Berl). 10.1515/dx-2022-0119. (Epub ahead of print. PMID: 36482753) - PMC - PubMed
    1. Sarsu SB, Erbagci AB, Ulusal H, Karakus SC, Bulbul ÖG (2017) The Place of Calprotectin, Lactoferrin, and High-Mobility Group Box 1 Protein on Diagnosis of Acute Appendicitis with Children. Indian J Surg 79(2):131–136. 10.1007/s12262-015-1441-2. (Epub 2016 Jan 14. PMID: 28442839; PMCID: PMC5386938) - PMC - PubMed